IL-2   Click here for help

GtoPdb Ligand ID: 4985

Synonyms: aldesleukin | interleukin-2 | Proleukin®
Approved drug Immunopharmacology Ligand
IL-2 is an approved drug (FDA (1992))
Comment: IL-2 and IL-15 are cytokines that share common biological effects, but also exhibit distinct, and sometimes competing, functions [6]. Recombinant IL-2 is used clinically with the generic name aldesleukin.
Abbas et al. (2018) have written a review of IL-2 biology and the progress that has been made in developing IL-2 therapeutics [1].
Species: Human
No information available.
Summary of Clinical Use Click here for help
Aldesleukin is US FDA approved to treat metastatic renal cell carcinoma. The FDA has also granted orphan designation for non-Hodgkin's lymphoma (1998), primary immunodeficiency disease associated with T-cell defects (1989) and metastatic melanoma (1996). The EMA's orphan designation for renal cell carcinoma was withdrawn by the drug's sponsor.